- Vokes, E. E., Mornex, F., Sezer, A., Cheng, Y., Fang, J., Baz, D. V., Cil, T., Adjei, A. A., Ahn, M.-J., Barlesi, F., Felip, E., Garon, E. B., Audhuy, F., Ito, R., Sato, M., Eggleton, S. P., Martin, C. M., Reck, M., Robinson, C. G., & Paz-Ares, L. (2023). Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study. Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2023.09.1452
Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study
on 15 de gener de 2024
with No hi ha comentaris
Deixa un comentari